1. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Wilson PW, Levy D. Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study. Arch Intern Med. 1999; 159:2206–2212.
2. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34:2159–2219.
3. Shin J, Park JB, Kim KI, et al. 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertension. Clin Hypertens. 2015; 21:2.
4. Noh J, Kim HC, Shin A, et al. Prevalence of comorbidity among people with hypertension: The Korea National Health and Nutrition Examination Survey 2007-2013. Korean Circ J. 2016; 46:672–680.
5. Steinman MA, Lee SJ, Boscardin WJ, et al. Patterns of multimorbidity in elderly veterans. J Am Geriatr Soc. 2012; 60:1872–1880.
6. Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016; 26:364–373.
7. Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care. 2011; 34:1323–1328.
8. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837–1847.